CC BY-NC-ND 4.0 · Thorac Cardiovasc Surg Rep 2020; 09(01): e51-e54
DOI: 10.1055/s-0040-1716391
Case Report: Cardiac

Cardiac Phlegmon: Infectious Endocarditis Causing Ventricular Wall Rupture

1   Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery, Hannover Medical School, Hannover, Germany
2   Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany
,
Igor Tudorache
1   Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery, Hannover Medical School, Hannover, Germany
,
Matthias Christgen
3   Institute of Pathology, Hannover Medical School, Hannover, Niedersachsen, Germany
,
Serghei Cebotari
1   Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery, Hannover Medical School, Hannover, Germany
› Author Affiliations

Abstract

Background Rupture of the cardiac ventricular wall is a rare and essentially lethal complication of infectious endocarditis valvularis.

Case Description We report a case of a 49-year-old female patient with infectious endocarditis of the aortic valve. Following aortic valve replacement, the patient developed a sudden free left ventricular wall rupture. Immediate reoperation was successful. Histopathology revealed a myocardial infarction due to septic thromboembolism causing a phlegmonlike myocardial appearance.

Conclusion This is a rare case of a myocardial phlegmon with subsequent cardiac lateral wall rupture in the context of an infectious endocarditis with septic coronary embolism.



Publication History

Received: 03 December 2019

Accepted: 24 January 2020

Article published online:
02 November 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 Mostaghim AS, Lo HYA, Khardori N. A retrospective epidemiologic study to define risk factors, microbiology, and clinical outcomes of infective endocarditis in a large tertiary-care teaching hospital. SAGE Open Med 2017; 5: 2050312117741772
  • 2 Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova NN. Trends in infective endocarditis in California and New York State, 1998–2013. JAMA 2017; 317 (16) 1652-1660
  • 3 Pant S, Patel NJ, Deshmukh A. et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol 2015; 65 (19) 2070-2076
  • 4 Tayama E, Chihara S, Fukunaga S, Akashi H, Aoyagi S, Mizoguchi K. Embolic myocardial infarction and left ventricular rupture due to mitral valve endocarditis. Ann Thorac Cardiovasc Surg 2007; 13 (03) 206-208
  • 5 Dickens P, Ho J, Wong KY. Sudden death from ruptured septic myocardial infarct in an intravenous drug addict. Forensic Sci Int 1995; 75 (01) 67-72
  • 6 Habib G, Lancellotti P, Antunes MJ. et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36 (44) 3075-3128
  • 7 Osula S, Lowe R, Perry RA. Cardiac rupture caused by Staphylococcus aureus septicaemia and pericarditis: an incidental finding. Heart 2001; 85 (03) E4
  • 8 Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005; 79 (03) 1072-1080